Research Papers

25 of 425 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Mul…
Flamm SL; Pockros PJ; Bengtsson L; Friedman M.
J Clin Transl Hepatol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Maternal-Fetal Hepatitis E Transmission: Is It Underestimated?
El Sayed Zaki M; El Razek MM; El Razek HM.
J Clin Transl Hepatol (Unknown)
Published: 2014
1/6 Transparent
Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges.
Yan YP; Su HX; Ji ZH; Shao ZJ; Pu ZS.
J Clin Transl Hepatol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury.
Krueger W; Boelsterli UA; Rasmussen TP.
J Clin Transl Hepatol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Acetaminophen-induced Liver Injury: from Animal Models to Humans.
Jaeschke H; Xie Y; McGill MR.
J Clin Transl Hepatol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Percutaneous Cryoablation for Liver Cancer.
Niu LZ; Li JL; Xu KC.
J Clin Transl Hepatol (Unknown)
Published: 2014
1/6 Transparent
Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management.
Kakati B; Seetharam A.
J Clin Transl Hepatol (Unknown)
Published: 2014
1/6 Transparent
Update on Hepatitis B Virus Infection: Focus on Treatment.
Hadziyannis SJ.
J Clin Transl Hepatol (Unknown)
Published: 2014
1/6 Transparent
Hepatitis B and Hepatitis C Reactivation in the Biologic Era.
Bojito-Marrero L; Pyrsopoulos N.
J Clin Transl Hepatol (Unknown)
Published: 2014
1/6 Transparent
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma.
Yao M; Wang L; Yao Y; Gu HB; Yao DF.
J Clin Transl Hepatol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic.
Andersen H; Meyer J; Freeman J; Doyle SE; Klucher K; Miller DM; Hausman D; Hillson JL.
J Clin Transl Hepatol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
Teschke R; Eickhoff A; Schulze J.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B.
Tang H; Griffin J; Innaimo S; Lehman-Mckeeman L; Llamoso C.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Genome-Wide Association Study Reveals Host Genetic Factors for Liver Diseases.
Nishida N; Tokunaga K; Mizokami M.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response.
Asahina Y; Nakagawa M; Kakinuma S; Watanabe M.
J Clin Transl Hepatol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Advances in Nucleotide Antiviral Development from Scientific Discovery to Clinical Applications: Tenofovir Disoproxil F…
Lou L.
J Clin Transl Hepatol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine…
Howe AY; Venkatraman S.
J Clin Transl Hepatol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Update on the Development of Anti-Viral Agents Against Hepatitis C.
Macarthur KL; Smolic R; Smolic MV; Wu CH; Wu GY.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease.
Kapila N; Higa JT; Longhi MS; Robson SC.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.
Gao W; Fan YC; Zhang JY; Zheng MH.
J Clin Transl Hepatol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.
Baffy G.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Update on Hepatitis C Virus and HIV Coinfection.
Gemtessa TA; Chirch LM.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Diagnosis of Liver Involvement in Primary Sjögren Syndrome.
Zeron PB; Retamozo S; Bové A; Kostov BA; Sisó A; Ramos-Casals M.
J Clin Transl Hepatol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
The Effect of Adrenal Replacement Therapy on Rates of Fungal Colonization and Mortality in Critically Ill Patients Awai…
Yi SG; Sadhu AR; Jones SL; Turner K; Monsour H; Donahue K; Xia X; Gaber AO; Ghobrial RM; Burroughs SG.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent
Development of Tivantinib as Treatment for Hepatocellular Carcinoma.
Au J; Frenette C.
J Clin Transl Hepatol (Unknown)
Published: 2013
1/6 Transparent